cbdMD, Inc. Common Stock

YCBD

cbdMD, Inc. (YCBD) is a health and wellness company focused on producing and marketing hemp-derived CBD products, including tinctures, topicals, and pet products. The company emphasizes quality, transparency, and broad-spectrum CBD formulations, aiming to serve consumers seeking natural wellness solutions.

$0.84 -0.03 (-3.65%)
🚫 cbdMD, Inc. Common Stock does not pay dividends

Company News

Stock Market Today: Dow Jones, S&P 500 Futures Climb At The Start Of Christmas Week— Kemper, Trump Media & Technology, cbdMD In Focus (UPDATED)
Benzinga • Rishabh Mishra • December 22, 2025

U.S. stock futures rose on Monday as markets enter the Christmas week with abbreviated trading. The S&P 500, Nasdaq 100, and other major indices advanced in premarket trading. Key movers included Trump Media & Technology surging on a $6 billion merger completion, Kemper tumbling after a downgrade, and cbdMD rising despite missing earnings expecta...

Why Are cbdMD (YCBD) Shares Surging 55% After Hours?
Benzinga • Mohd Haider • December 12, 2025

cbdMD regained full compliance with NYSE American listing standards, resulting in a significant after-hours stock price increase of 54.64%.

How Trump Has Fired Up Cannabis Stocks
Investing.com • Dave Kovaleski • September 29, 2025

Donald Trump's video on Truth Social praising hemp-derived CBD's health benefits triggered a significant surge in cannabis and CBD-related stocks, with some companies experiencing dramatic price increases.

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga • Benzinga Staff Writer • September 29, 2025

Multiple health care and biotech stocks experienced significant price movements, with some stocks seeing substantial gains while others faced sharp declines during Monday's trading session.

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga • Avi Kapoor • January 9, 2024

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. JetBlue’s President & COO Joanna Geraghty will succeed Robin Hayes as CEO, effective Feb. 12, 2024. B of A Securities analyst Andrew Didora downgrades JetBlue Airways from Neutral to Underperform and lowered the price target from $6 to $3. JetBlue Airw...

Related Companies